Apolipoprotein-D: A Novel Cellular Marker for HGPIN and Prostate Cancer

Prostate

Volumn 58, Issue 2, 2004, Pages 103-108

  Hall, R E ^b   Horsfall, D J ^a   Stahl, J ^b   Vivekanandan, S ^b   Ricciardelli, C ^a   Stapleton, A M F ^c   Scardino, P T ^d   Neufing, P ^a   Tilley, Wayne D ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b FLINDERS UNIVERSITY   (Australia)

^c REPATRIATION GENERAL HOSPITAL   (Australia)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Apolipoprotein D; Prostate specific antigen; Prostatic intraepithelial neoplasia; Radical prostatectomy

Indexed keywords

ANDROGEN; APOLIPOPROTEIN D; CARRIER PROTEIN; PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

ARTICLE; CANCER GRADING; EPITHELIUM CELL; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOREACTIVITY; MALE; MALIGNANT TRANSFORMATION; PRECANCER; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROTEIN EXPRESSION;

APOLIPOPROTEINS; APOLIPOPROTEINS D; CELL TRANSFORMATION, NEOPLASTIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOASSAY; MALE; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; VIDEO RECORDING;

EID: 0742322680     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/pros.10343     Document Type: Article

References (32)

1. McNeal JE. Morphogenesis of prostate carcinoma. Cancer 1965;18:1659-1666.
2. McNeal JE, Bostwick DG. Intraductal dysplasia: A premalignant lesion of the prostate. Hum Pathol 1986;17:64-71.
3. Bostwick DG. High grade prostatic intraepithelial neoplasia-The most likely precursor of prostate cancer. Cancer 1995;75:1823-1836.
4. Bostwick DG, Pacelli A, Lopez-Beltran A. Molecular biology of prostatic intraepithelial neoplasia. Prostate 1996;29:117-134.
5. Myers RB, Grizzle WE. Biomarker expression in prostatic intraepitheliaheoplasiaEur Urol 1996;30:153-166.
6. Haggman MJ, Macoska JA, Wojno KJ, Oesterling JE. The relationship between prostatic intraepithelial neoplasia and prostate cancer: Critical issues. J Urol 1997;158:12-22.
7. Luo J, Zha S, Gage WR, Dunn TA, Hicks JL, Bennett CJ, Ewing CM, Platz EA, Ferdinandusse S, Wanders RJ, Trent JM, Isaacs WB, De Marzo AM. Alpha-methylacyl-CoA racemase: A new molecular marker for prostate cancer. Cancer Res 2002;62:2220-2226.
8. Feneley MR, Green JSA, Young MPA, Bose P, Kirby RS, Peeling WB, Parkinson MC. Prevalence of prostatic intraepithelial neoplasia (PIN) in biopsies from hospital practice and pilot screening: Clinical implications. Prost Cancer Prost Dis 1997;1:79-83.
9. Fowler JE Jr., Bigler SA, Miles D, Yalkut DA. Predictors of first repeat biopsy cancer detection with suspected local stage prostate cancer. J Urol 2000;163:813-818.
10. Yasunaga Y, Shin M, Fujita MQ, Nonomura N, Miki T, Okuyama A, Aozasa K. Different patterns of p53 mutations in prostatic intraepithelial neoplasia and concurrent carcinoma: Analysis of microdissected specimens. Lab Invest 1998;78:1275-1279.
11. 2u-globulin super-family. DNA 1987;6:199-204.
12. Balbín M, Freije JM, Fueyo A, Sanchez LM, Lopez-Otin C. Apolipoprotein D is the major protein component in cyst fluid from women with human breast gross cystic disease. Biochem J 1990;271:803-807.
13. Haagensen DE, Stewart P, Dilley WG, Wells SA. Secretion of breast gross cystic disease fluid proteins by T47D breast cancer cells in culture-Modulation by steroid hormones. Breast Cancer Res Treat 1992;23:77-86.
14. Simard J, de Launoit Y, Haagensen DE, Labrie F. Additive stimulatory action of glucocorticoids and androgens on basal and estrogen-repressed apolipoprotein-D messenger ribonucleic acid levels and secretion in human breast cancer cells. Endocrinology 1992;130:1115-1121.
15. Simard J, Veilleux R, de Launoit Y, Haagensen DE, Labrie F. Stimulation of apolipoprotein D secretion by steroids coincides with inhibition of cell proliferation in human LNCaP prostate cancer cells. Cancer Res 1991;51:4336-4341.
16. Sugimoto K, Simard J, Haagensen DE, Labrie F. Inverse relationship between cell proliferation and basal or androgen-stimulated apolipoprotein D secretion in LNCaP human prostate cancer cells. J Steroid Biochem Mol Biol 1994;51:167-174.
17. López-Boado YS, Tolivia J, López-Otín C. Apolipoprotein D gene induction by retinoic acid is concomitant with growth arrest and cell differentiation in human breast cancer cells. J Biol Chem 1994;269:26871-26878.
18. 3 is accompanied by induction of apolipoprotein D expression. Cancer Res 1997;57:4091-4097.
19. Aspinall JO, Bentel JM, Horsfall DJ, Haagensen DE, Marshall VR, Tilley WD. Differential expression of apolipoprotein-D and prostate specific antigen in benign and malignant prostate tissues. J Urol 1995;154:622-628.
20. Zhang SX, Bentel JM, Ricciardelli C, Horsfall DJ, Haagensen DE, Marshall VR, Tilley WD. Immunolocalization of apolipoprotein D, androgen receptor, and prostate specific antigen in early stage prostate cancers. J Urol 1998;159:548-554.
21. O'Malley FP, Grignon DJ, Shum DT. Usefulness of immunoperoxidase staining with high-molecular-weight cytokeratin in the differential diagnosis of small-acinar lesions of the prostate gland. Virchows Archiv A Pathol Anat 1990;417:191-196.
22. Tilley WD, Lim-Tio SS, Horsfall DJ, Aspinall JO, Marshall VR, Skinner JM. Detection of discrete androgen receptor epitopes in prostate cancer by immunostaining: Measurement by color video image analysis. Cancer Res 1994;54:4096-4102.
23. Epstein JI, Grignon DJ, Humphrey PA, McNeal JE, Sesterhen IA, Troncoso P, Wheeter TM. Interobserver reproducibility in the diagnosis of prostatic intraepithelial neoplasia. Am J Surg Pathol 1995;19:873-886.
24. McNeal JE, Alroy J, Leav I, Redwine EA, Freiha FS, Stamey TA. Immunohistochemical evidence for impaired cell differentiation in the premalignant phase of prostate carcinogenesis. Am J Clin Pathol 1988;90:23-32.
25. Abrahamsson PA, Lilja H, Falkmer S, Wadstrom LB. Immunohistochemical distribution of the three predominant secretory proteins in the parenchyma of hyperplastic and neoplastic prostate glands. Prostate 1988;12:39-46.
26. Poulin R, Baker D, Labrie F. Androgens inhibit basal and estrogen-induced cell proliferation in the ZR-75-1 human breast cancer cell line. Breast Cancer Res Treat 1988;12:213-225.
27. Blais Y, Sugimoto K, Carriere MC, Haagensen DE, Labrie Simard J. Potent stimulatory effect of interleukin-1α on apolipoprotein-D and gross cystic disease fluid protein-15 expression in human breast cancer cells. Int J Cancer 1994;59:400-407.
28. Visakorpi T, Hyytinen E, Koivisto P, Tanner M, Keinanen R, Palmberg C, Palotie A, Tammela T, Isola J, Kallioniemi OP. In vivo amplification of the androgen receptor gene and progression of human prostate cancer. Nat Genet 1995;4:401-406.
29. Brown RS, Edwards J, Dogan A, Payne H, Harland SJ, Bartlett JM, Masters JR. Amplification of the androgen receptor gene in bone metastases from hormone-refractory prostate cancer. J Pathol 2002;2:237-244.
30. Jarrard DF, Kinoshita H, Shi Y, Sandefur C, Hoff D, Meisner LF, Chang C, Herman JG, Isaacs WB, Nassif N. Methylation of the androgen receptor promoter CpG island is associated with loss of androgen receptor expression in prostate cancer cells. Cancer Res 1998;58:5310-5314.
31. Sasaki M, Tanaka Y, Perinchery G, Dharia A, Kotcherguina I, Fujimoto S, Dahiya R. Methylation and inactivation of estrogen, progesterone, and androgen receptors in prostate cancer. J Natl Cancer Inst 2002;94:384-390.
32. Hall RE, Vivekanandan S, Ricciardelli C, Stapleton A, Scardino P, Stahl J, Haagensen DE, Marshall VR, Tilley WD. Androgen receptor and apolipoprotein-D: diagnostic and prognostic significance in prostate cancer. Amer. Assoc. Cancer Res. 90th Annual Meeting, Philadelphia 1999, Abstract #2700.